Last reviewed · How we verify
AX-024.HCl
At a glance
| Generic name | AX-024.HCl |
|---|---|
| Sponsor | Artax Biopharma Inc |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Potential Food Effect And Repeated Dosing of AX-024.HCl In Healthy Subjects (PHASE1)
- Safety Study of Immune System Modulator for Autoimmune Diseases (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AX-024.HCl CI brief — competitive landscape report
- AX-024.HCl updates RSS · CI watch RSS
- Artax Biopharma Inc portfolio CI